Obesity is a global public health problem of crucial importance. Obesity rates remain high in high-income countries and are rapidly increasing in low- and middle- income countries. Concurrently, the global consumption of unhealthy products, such as soft drinks and processed foods, continues to rise. The ongoing expansion of multinational food and beverage companies, or 'Big Food', is a key factor behind these trends. This collection provides critical insight into the global expansion of 'Big Food', including its incursion into low-and-middle income countries. It examines the changing dynamics of the global food supply, and discusses how low-income countries can alter the 'Big Food'-diet from the bottom-up. It examines a number of issues related to 'Big Food' marketing strategies, including the way in which they advertise to youths and the rural poor. These issues are discussed in terms of their public health implications, and their relation to public health activities, for example 'soda taxes', and the promotion of nutritionally-healthier products. This book was originally published as a special issue of Critical Public Health.

From business models to unique selling propositions, from product offerings to sales, marketing and pricing strategies, this book reveals what sets Chinese electric car manufacturers apart from their Western counterparts. Chinese automakers are gradually establishing themselves as the new trendsetters in the automotive industry as they make technological advances in various fields, especially in electric vehicles. As more of them look overseas for opportunities, especially in the European market, it is time for the local players to better understand who they are up against and take steps to keep up with the rapid growth of their Far Eastern competitors. Based on Simon-Kucher's project experience, this book shows what is going on behind the Great Wall, informs readers about the latest technological trends and advances in China, and offers suggestions on what Chinese newcomers should bring with them when they come to town. Sharing valuable insights for all readers with an interest in the electric vehicle (EV) industry, this book will be particularly relevant for managers and decision-makers at Western OEMs, suppliers, and other relevant players in the automotive industry.

Innovations of agri-food systems during the last 50 years have been guided by a globalized agro-industrial paradigm, which has contributed to climate change, degradation of natural resources, soil depletion, social inequalities, loss of biodiversity and various food-related health problems. Despite the increasing emphasis of food policies and research to address these issues with ecologically sustainable innovations, there are still no studies that explain how to utilize and integrate ecodesign practices in food products development in a world of finite resources. This book explains how to employ ecodesign in business models to address the economic, social, environmental, and nutritional problems that face the world s food systems. The lessons of the EcoTrophelia project ? a unique program implemented by a group of European agricultural higher education institutions to involve students in designing and developing food ecoinnovation projects ? are explored. Through an analysis of these projects, the authors describe the tools, methods and standards that were developed to institute ecodesign into the business models of 11 ecologically-friendly food products. This book provides operational good practices that can be implemented in educational programs and agri-food industries, to orient learning and practices towards greater sustainability.

Chinese manufacturing industries continue to impact the world economy. It is important to understand what is happening in China and the uniqueness of Chinese manufacturing industries. Manufacturing Productivity in China brings together a group of authors from academia and industry to give an industrial engineering micro viewpoint instead of an economical macro viewpoint to this subject. It includes first-hand case studies to better understand the competitiveness of Chinese manufacturing industries. Although many researchers attribute China's manufacturing success to the competitiveness of low labor and materials cost, in reality, many other factors are at play. Investment in manufacturing engineering education and innovation also plays a role. With twelve case studies written by foremost authorities from Tsinghua University, this book covers a broad range of manufacturing industries-transitional, state-owned, and private enterprises. However, each case study highlights the innovation of Chinese manufacturing and enhancement of production efficiency, with concepts bolstered by a significant number of figures and tables. The book explores the history of China's success, beginning with the planned economy from 1949-1977, to the reforms of the latter part of the twentieth century, to the emergence of industrial engineering and innovation. An inside look at the stories behind the successful manufacturing processes, this book provides an unbiased view of the success of "Made in China".

An illustrated introduction to how British industries, supported by thousands of newly recruited women, strove to meet the nation's wartime need for munitions, armour, shipping, uniforms and aircraft. During the Second World War (1939-45), Britain stretched every sinew of its industrial might to fend off a Nazi invasion. As the nation stood alone against Fortress Europe, it harnessed, coordinated and maximised its resources, firstly to defend itself and then to help liberate Axis-occupied countries. Wartime Industry uses informative text and beautiful illustrations to show how the men and women of Britain met this unprecedented demand for military and home-front materials. It explores the work of Lord Beaverbrook's highly organised Ministry of Aircraft Production; the 'Shadow Factories' that enabled manufacturers such as Vauxhall and Rootes to make tanks and aircraft; the Royal Ordnance Factories that produced firearms and explosives; the 'Bevin Boys' conscripted to work in the coal mines; the Women's Timber Corps; and war workers - who, together, helped the nation to make it.

This book introduces the applications of Industry 4.0 in machine tools through an overview of the latest available digital technologies. It focuses on digital twining, communication between industrial controls, motion, and input/output devices, along with sustainability in SMEs. Machine Tools: An Industry 4.0 Perspective focuses on the digital twining of machine tools, which improves the life of the machines and provides a method of operating a factory during times of complete lockdown resulting from various conditions. It presents an overview of the communication between industrial controls, motion, and input/output devices through standardized digital interfaces such as SERCOS and USB. The book goes on to discuss industrial cybersecurity systems applicable to discrete manufacturing, which includes cyberattacks and human errors, and address the security aspects related to software, hardware, and data. The book also explores the application of big data for different stages of production and illustrates the uses such as predictive maintenance, product quality, product life cycle management (PLM), and more. This book is an ideal reference for undergraduate, graduate, and postgraduate students of industrial, mechanical, and mechatronics engineering, along with professionals, and general readers.

An analysis of the impact of inward investment on the competitiveness of indigenous firms, Multinational Enterprises and Technological Spillovers draws on evidence from the UK and Italian manufacturing sectors to show how foreign presence may generate both virtuous and vicious circles of development according to a number of interrelated factors. These include the level of the foreign presence, its rate of increase, the technological disparities between foreign and indigenous firms and the political response. An examination of the productive and innovatory activities of US and Japanese firms in Europe is also provided to enlighten the differential role of European countries in the global operations of overseas multinationals.

This classic work, first published in 1958, is a seminal text in international business history. This new, substantially updated and revised edition is being published on the fortieth anniversary of the first edition. Features of the revised edition include: * a new introduction * a new concluding chapter * amendments and additions to the original text * a new statistical appendix which examines the main features and significance of the US penetration of UK industry over the past four decades. Professor Dunning is one of the most internationally renowned and respected scholars in international business research. The updated version of this highly regarded book is a major contribution to studies in international business history.

The years since the global financial crisis have seen something of a renaissance in the manufacturing industry. The United States has launched its Advanced Manufacturing Partnership, and China owes much of its spectacular economic boom in the last decades to its being the 'world's factory'. Is there room for the EU in this landscape? This timely new book explores Europe's role in this evolving environment. It argues that on the one hand, in terms of sheer numbers, the role of the manufacturing industry in the EU is on a par with other major global economies. However, the book also states that Europe falls short of its global competitors (the USA in particular) in terms of its involvement in the most innovative manufacturing sectors. The volume therefore argues that this creates the opportunity for a new European industrial policy. Exploring the development of current EU policy, the book puts forward suggestions as to how the EU can improve in terms of the competitiveness of its technology policy. Placing the EU's position in the context of the industrial structures of the USA, Japan and the BRICs, the book blends theoretical models and practical examples in order to offer a the state of the art look at the current and future direction of Europe's industrial policy. This book will be of relevance to all those with an interest in European economics, industrial economics, public policy, European politics and European studies.

Bikash Chatterjee emphasizes the criticality of applying the principles of Lean and Six Sigma within the paradigm of the drug development process. His guide to operational excellence in the pharmaceutical and biotech industries is a focused summary of the application of Lean Six Sigma theory to the regulated life sciences. From molecule discovery to the application of PAT Applying Lean Six Sigma in the Pharmaceutical Industry will highlight the importance of framing these initiatives within the key deliverables of drug development manufacturing and quality. Challenging conventional wisdom the author offers a quality and efficiency perspective as a foundation for the principles of Quality by Design, PAT and the new philosophies underlying Process Validation. Each chapter includes discussion around the considerations for applying Lean manufacturing and Six Sigma principles and their tools, culminating in a case study to illustrate the application. The book is organized to reflect the major work centers involved in the drug development lifecycle. Each chapter is stand-alone but together they illustrate the necessary synergy between Lean, Six Sigma and compliance sensibilities required to be successful in the pharmaceutical industry. These design, manufacturing and management techniques are not without their challenges. Bikash Chatterjee's book offers the roadmap for an industry that is struggling to reinvent many of its development and business processes.

A 2017 Michigan Notable Book After World War II, the American automobile industry was reeling. Having spent years building tanks and airplanes for the army, the car companies would need years more to retool their production to meet the demands of the American public, for whom they had not made any cars since 1942.    And then in stepped Preston Tucker. This salesman extraordinaire from Ypsilanti, Michigan, had built race cars before the war, and had designed prototypes for the military during it. Now, gathering a group of brilliant automotive designers, engineers, and promoters, he announced the creation of a revolutionary new car: the Tucker '48, the first car in almost a decade to be built fresh from the ground up. Tucker's car would include ingenious advances in design and engineering that other car companies could not match. With a rear engine, rear-wheel drive, a safety-glass windshielf that would pop out in case of an accident, a padded dashboard, independent suspension, and automatic transmission, it would be more attractive and aerodynamic—and safer—than any other car on the road.    But as the public eagerly awaited Tucker's car of tomorrow, powerful forces in Washington were trying to bring him down. An SEC commissioner with close ties to Detroit's Big Three automakers deliberately leaked information about an investigation the agency was conducting, suggesting that Tucker was bilking investors with a massive fraud scheme. Headlines accused him a perpetrating a hoax and claimed that his cars weren't real and his factory was a sham.  In fact, the Tucker '48 sedan was genuine, and everyone who saw it was impressed by what this upstart carmaker had achieved. But the SEC's investigation had compounded the company's financial problems and management conflicts, and a superior product was not enough to keep Tucker's dream afloat.  Here, Steve Lehto tackles the story of Tucker's amazing rise and tragic fall, relying on a huge trove of documents that has been used by no other writer to date. It is the first comprehensive, authoritative account of Tucker's magnificent car and his battles with the government. And in this book, Lehto finally answers the questions automobile aficionados have wondered about for decades: Exactly how and why was the production of such an innovative car killed?

Antioxidants Effects in Health: The Bright and the Dark Side examines the role that antioxidants play in a variety of health and disease situations. The book discusses antioxidants' historical evolution, their oxidative stress, and contains a detailed approach of 1) endogenous antioxidants, including endogenous sources, mechanisms of action, beneficial and detrimental effects on health, in vitro evidence, animal studies and clinical studies; 2) synthetic antioxidants, including sources, chemistry, bioavailability, legal status, mechanisms of action, beneficial and detrimental effects on health, in vitro evidence, animal studies and clinical studies; and 3) natural antioxidants, including sources, chemistry, bioavailability, mechanisms of action, possible prooxidant activity; beneficial and detrimental effects on health, in vitro evidence, animal studies and clinical studies. Throughout the boo, the relationship of antioxidants with different beneficial and detrimental effects are examined, and the current controversies and future perspectives are addressed and explored. Antioxidants Effects in Health: The Bright and the Dark Side evaluates the current scientific evidence on antioxidant topics, focusing on endogenous antioxidants, naturally occurring antioxidants and synthetic antioxidants. It will be a helpful resource for pharmaceutical scientists, health professionals, those studying natural chemistry, phytochemistry, pharmacognosy, natural product synthesis, and experts in formulation of herbal and natural pharmaceuticals.

Although traditional manufacturing (textiles, clothing, footwear, furniture, etc) has been in decline in developed countries, it still represents an important part of European employment due to its labour-intensive character. Moreover, its geographical concentration particularly exposes certain regions of Europe to job loss as the industry declines. This book provides an explanation for the differences observed in the impact of globalization which is based on the influence of the territory and of the production specialization of the firms. The conclusions presented in the book are withdrawn from a detailed study of the Spanish textile-clothing sector. The book highlights the intensity of the relationship between the organizational model of the territory where the firms are located (high concentration of interrelated firms in a well-defined geographical area called "industrial district"), the specialization strategy implemented and the globalization of the economy. It also suggests the need to consider those factors as interdependent determinants of firm performance, particularly given the current trend for firms to simultaneously concentrate geographically and multilocalize domestically and internationally. The proposed methodology of analysis can be used to study other manufacturing sectors in other European countries.

The food stories behind your favourite fruits and vegetables. Have you ever wondered who picked your Fairtrade banana? Or why we can buy British strawberries in April? How far do you think your green beans travelled to get to your plate? And where do all the wonky carrots go? Above all, how do we stop worrying about our food choices and start making decisions that make a difference? In an effort to make sense of the complex food system we are all part of, Louise Gray decides to track the stories of our five-a-day, from farm to fruit bowl, and discover the impact that growing fruits and vegetables has on the planet. Through visits to farms, interviews with scientists and trying to grow her own, she digs up the dirt behind organic potatoes, greenhouse tomatoes and a glut of courgettes. In each chapter, Louise answers a question about a familiar item in our shopping basket. Is plant protein as good as meat? Is foraged food more nutritious? Could bees be the answer to using fewer chemicals? How do we save genetic diversity in our apples? Are digital apps the key to reducing food waste? Is gardening good for mental health? And is the symbol of clean eating, the avocado, fuelling the climate crisis? As pressure grows via social media to post pictures of food that ticks all the boxes in terms of health and the environment, these food stories from the author of the award-winning The Ethical Carnivore are also a personal story of motherhood and the realisation that nothing is ever perfect.

Following the journey of eight bargain store objects, Alison Hulme reveals the complex story behind society's simplest and cheapest commodities. Inspired by Walter Benjamin's Arcades Project, On the Commodity Trail explores the colourful and fascinating histories of everyday objects.Along the way, we observe raw materials on municipal rubbish dumps in China, newly re-made products in the world's largest wholesale market, and take a journey across the seas, to bargain stores in Europe and North America, arriving finally in the homes of consumers. Weaving together narratives from the people we meet at different parts of the commodity chain - waste peddlers, wholesalers, store owners, and shoppers - the book examines the places and people at the heart of these localized yet immense global networks.Unlike other investigations of commodity chains, this study does not chart a straightforward trajectory from production to consumption. Instead, it demonstrates that the low-end commodity chain is one of constant rupture in which products are made and re-made, blurring the dividing line between producing and consuming.An ethnography of material culture as well as an examination of commodity culture at a time of economic downturn, this deeply-engrossing book makes a unique contribution to our understanding of commodity chains and consumer culture.

The biopharmaceutical industry has entered an era of unprecedented change and challenge, characterized by increasing pricing pressures, rising rates of attrition in the product development lifecycle, and decreasing scientific innovation. The most successful products are losing patent protection, and pipelines have been unable to fill the gap. This book explores the evolving definition of innovation in therapeutic product development and begins to examine its effects on the life sciences R&D industry. Historically, scientific innovation alone was sufficient to maintain ROI and deliver on unmet medical needs. However, with many forces now conspiring to increase pressures on the commoditization of drug development, industry support for truly novel, often high-risk development has eroded. This calls for a drastic redefinition of what "innovation" is. While innovation in the pharmaceutical R&D industry has historically been applied to major advances in therapy and unmet medical needs, we now need to see innovation increasingly defined in terms of financial, marketing (e.g. branded generics and emerging markets), pharmacoeconomic, and operational innovation. In this book, contributors drawn from the executive ranks of clinical development practitioners and stakeholders-from biopharmaceutical companies, clinical research organizations, academia, the financial community, and the patient perspective-have all come together to provide their expertise and visions. Their goal is to start a dialogue about ways to radically improve therapeutics development and get more and better medicines to the patients who need them, as fast as possible, in the most cost-efficient manner.

View the Table of Contents. Read the Introduction.

aStirring firsthand account of the SSRI wars. . . . Healy is a distinguished research and practicing psychiatrist, university professor, frequent expert witness, former secretary of the British Association for Psychopharmacology, and author of three books in the field. Instead of shrinking from commercial involvement, he has consulted for, run clinical trials for, and at times even testified for most of the major drug firms. But when he pressed for answers to awkward questions about side effects, he personally felt Big Pharma's power to bring about a closing of ranks against troublemakers. That experience among others has left him well prepared to puncture any illusions about the companies' benevolence or scruples.a
--"New York Review of Books"

"A compelling story about mystery, deception, death, disappointment, vindication, and uncertainty."
--"The American Psychological Association"

"Healy confirms his status as one longtime thorn in the side of big drug companies, recounting how he was initially enthusiastic about SSRIs but eventually grew concerned about their side effects."
--"Psychology Today"

"Physicians should be aware of Let Them Eat Prozac."
--"JAMA"

"Let Them Eat Prozac is a double-pronged exploration, first of the SSRI drugs used to treat depression, and second of the drug industry."
--"Publishers Weekly"

"Ultimately, the book is about science, society and the power and misuse of commercial promotion. . . . His investigation is impressive."
--"Nature"

"This very important book will demonstrate beyond your worst dreams that the commercial needs of Big Pharma are the natural-born enemyof independent scientific research."
--John Le CarrA(c)

"Healy presents technical matters clearly. This book could not be more timely."
--"Foreword"

"Let Them Eat Prozac is an interesting history. It asks some stimulating and challenging questions, which are still in need of better and more constructive answers."
--"Journal of the American Academy of Child Adolescent Psychiatry"

"In a flood of academic publications and talks, David Healy has issued harsh criticisms of both the pharmaceutical industry in general and the nearly $20-billion-dollar-a-year antidepressant industry in particular."
--"Boston Globe"

"Healy does raise some timely issues."
--"Psychiatric Services"

"Dr. Healy's tenacity in fighting for what he believes in is admirable."
--"E-Streams"

"[Healy is] the leading authority on the history of psychopharmacology."
--"Times Literary Supplement"

aAn alarming book. . . . The most disturbing part of the story Healy tells is not merely about the risks of SSRIs but about the efforts of the pharmaceutical industry to make sure those risks were not uncovered.a
--"Dissent"

"In his timely new book, Healy draws on his extensive experience in antidepressant studies and involvement in legal actions against drug manufacturers. . . . Healy has the advantage of access to internal pharmaceutical industry documents and makes a strong case."
--"Library Journal"

"The author is an excellent historian who offers a gripping interpretation of the role of the pharmaco-industrial complex in the introduction of SSRIs. His recommendation for a funded agency that would carefully evaluate the benefits and harms of marketed drugs is a superb idea andmuch needed."
--Jonathan Cole, Harvard Medical School

"Healy exposes the massive fraud and deception in the production and marketing of antidepressant drugs, the selevtive serotonin reuptake inhibitors (SSRIs)."
--"Choice"

Prozac. Paxil. Zoloft. Turn on your television and you are likely to see a commercial for one of the many selective serotonin reuptake inhibitors (SSRIs) on the market. We hear a lot about them, but do we really understand how these drugs work and what risks are involved for anyone who uses them?

Let Them Eat Prozac explores the history of SSRIs--from their early development to their latest marketing campaigns--and the controversies that surround them. Initially, they seemed like wonder drugs for those with mild to moderate depression. When Prozac was released in the late 1980s, David Healy was among the psychiatrists who prescribed it. But he soon observed that some of these patients became agitated and even attempted suicide. Could the new wonder drug actually be making patients worse?

Healy draws on his own research and expertise to demonstrate the potential hazards associated with these drugs. He intersperses case histories with insider accounts of the research leading to the development and approval of SSRIs as a treatment for depression. Let Them Eat Prozac clearly demonstrates that the problems go much deeper than a side-effect of a particular drug. The pharmaceutical industry would like us to believe that SSRIs can safely treat depression, anxiety, and a host of other mental problems. But, as Let Them Eat Prozac reveals, this "cure" may be worse than the disease.

This edited collection, first published in 1985, deals with a number of the major themes central to the study of industrial geography. Topics under discussion include new methodologies, the growing service industries, foreign investment and the industrial geography of the developing world. With a detailed introduction from Michael Pacione and comprehensive coverage, the title reflects the extent to which the field of industrial geography changed over the second half of the twentieth century in response to economic change, to incorporate the growth of multinational enterprises and the influence of globalisation, alongside traditional discussion of the manufacturing industry. Providing an essential background to developments in industrial geography, this title will be valuable to students with an interest in the economics, characteristics and advancement of industrial change.

- provides a comprehensive, global overview of sustainable diets, aligning health, agriculture, environment, economic and social policies and practices - offers recommendations that could help reverse global warming, reduce the triple burden of disease (under, over, and mal-nutrition) across nations while seeking to foster greater equity, health and well-being - will be appropriate for students, scholars, professionals and policymakers involved in food and agriculture, environmental policy, environmental and public health, environmental ethics and nutrition and dietetics.

The Pharmaceutical Industry has been undergoing a major transformation since the heady days of 'big pharma' in the 1970s and 80s. Patent expiry, the rise of generics, and the decline of the blockbuster drug have all changed the landscape over the last 10-15 years. It's an environment where products can take 10 years or more to come to market, billions are spent on research and development, jobs are being shed in the western pharma homelands and regulators and the public are more demanding than ever. So what part is Knowledge Management playing and going to play in this vital international industry? Knowledge Management (KM) has many facets from providing comprehensive knowledge bases for workers, through the sharing of advice and problem solving, to providing an environment for innovation and change. This book, focusing on research and development, and manufacturing-based companies, explores how a range of techniques and approaches have been applied in the unique environment of the Pharmaceutical Industry, and examine how it can help the industry in the 21st century. Whilst the book is centered on the Pharmaceutical Industry, its objective will be to discuss and demonstrate how Knowledge Management can be applied in a variety of environments, and with a range of cultural issues. KM practitioners, and potential practitioners, both within and outside the Pharmaceutical Industry, will be able to gain valuable guidance and advice from both the examples of good practice and the lessons learned by the authors and contributors.

In this fascinating history, Jeffrey Rothfeder tells how, from a simple idea - the outgrowth of a handful of peppers planted on an isolated island on the Gulf of Mexico - a secretive family business emerged that would produce one of the best-known products in the world. In short order, McIlhenny's descendants would turn Tabasco into a gold mine and an icon of pop culture, making it as recognisable as far bigger brands such as Coca-Cola and Kleenex.To this day, the McIlhenny Co., still run by a family of matchless characters who believe in a rigid code of family loyalty, clings to tradition and the old ways of doing business. Yet by fiercely protecting its beloved brand and refusing to sell out to big food conglomerates, this family business has run circles around its competitors, churning out annual revenues that have surpassed everyone's expectations. A satisfying read for business buffs, "McIlhenny's Gold" is the untold story of the continuing success of an eccentric, private company; a lively history of one of the most popular consumer products of all times.

This book offers a timely and critical reflection on how states have responded to the test of terrorism in the long shadow of 9/11. Terrorism has become the hallmark of international relations in the early twenty-first century. This book provides a policy-focused analysis of how certain states have responded to its test by employing a range of viewpoints that encompass state level responses down to a close interrogation of the nebulous non-state actors who have orchestrated spectacular political violence in contemporary times. It engages with the challenges of terrorism from a variety of perspectives that include philosophical discourses, the perils of counterterrorism encapsulated in the death of Jean Charles de Menezes, learning in counterinsurgency, the effectiveness of counterterrorism spending, Al Qaeda's modus operandi and the threat posed by Boko Haram to Nigeria. This eclectic collection of chapters is an important contribution to the wide-ranging and contested debate about terrorism that has dominated the political discourse in the West since 2001. This book was published as a special issue of Defense and Security Analysis.

This book describes a number of different empirical studies and evaluations of the international brewery industry. This industry has recently undergone two climactic changes within a ten to fifteen year time period. These are a significant industry-wide consolidation of firms and market shares accompanied by the internationalization of what was previously a largely local industry. Understanding the drivers and implications of such abrupt and massive change in the competitive environment of an industry is of great interest to international and strategic management scholars. Most of the book's chapters address this issue, some at the global industry level, some at a regional level, and some at the level of a specific country. Taken together, they comprise an insightful case study of an interesting industry at its most interesting point in time.' - William G. Egelhoff, Fordham University, US'The individual contributions in this volume paint a varied and rich picture of strategies and rivalries, the role of environments and institutions, leadership and also customer approaches in both global and local brewery industry. Some of the analysed phenomena are more standard to an IB audience, like consolidation, technological development, and shifts in global markets, but they get a specific flavor and color through this industry focus, while other topics definitely seem more specific (like 'Bierstrasse' on Mallorca). For readers with good taste.' - Rian Drogendijk, Uppsala University, Sweden This unique book explores some of the key topics of international business through the context of a global industry, focusing on the challenges brewery companies face as they operate in globalized markets. It examines the strategies of individual firms to develop markets and explores new insights into recent company rivalries, both globally and locally. In addition, it offers detailed analysis of some of the major players in the industry through longitudinal studies. Drawing on a range of perspectives, the contributing authors explore six overarching themes: international market developments and firm performance; host country institutional effects; multi-point competition and rivalries; cross-border M&A integration and subsidiary development; leadership and internationalization; and boundless customer interfaces through such elements as social media and tourism. The Global Brewery Industry will prove insightful for scholars across international business, as well as providing an appealing case study for advanced students. It will be invaluable to those investigating the brewery sector specifically, or working with brewing firms. Contributors: M. Andersson, C. Doerrenbacher, J. Gammelgaard, M. Geppert, M. Gilles, M.W. Hansen, B. Hobdari, A.K. Hoenen, G. Hollinshead, K. Jakobsen, A. Kokko, A. Kuusik, J. Larimo, L. Lund-Thomsen, M. Maclean, E.S. Madsen, A.M. Munar, K. Pedersen, N. Pogrebnyakov, C. Ruhe, J. Smith, S. Takeshita, I.M. Taplin, S. Troll, U. Varblane, C. Williams, A. Zaby

In Transforming Big Pharma John Ansell addresses critically how strategy works in the pharmaceutical industry. The long-standing dearth of new products has led to a growing shortfall in revenues. Ansell assesses the wide range of alternative strategies big pharma companies have been pursuing in recent years in attempting to overcome this. He shows that there is sound evidence to expect the recent upturn in the number of new products reaching the market to go on to greater heights. Chapters assess the complex trends in attrition rates, show how rife spectacular sales underestimation in the industry remains, and explain how conventional wisdom on the chances of product profitability also seriously undersells the industry. The surest route to transforming the prospects for big pharma, Ansell contends, is to step up activity in acquiring and developing new products. This is now realistic because, as he shows, the amount of intellectual property available is much greater than it was a decade ago. Ansell believes that no other strategies have sufficient transformative powers, though they may be useful as a stopgap whilst the sales of forthcoming new products mature. He argues for a reversal of big pharma's recent cutbacks in R&D and licensing, and re-focussing on new product development. Transforming Big Pharma is intended for those in senior and middle management in the pharmaceutical industry. It will also be valuable to students, as well as to all those dealing with the industry, including biotech companies and those providing services and products to the pharmaceutical industry.

1) Enables engineers to meet international standards such as ISO 55 000. 2) Includes statistics essential to basic understanding of reliability engineering theory 3) Covers both high and low budget plants, alongside describing how to retrofit older plants and how to set up new plants 4) Includes a chapter on root cause analysis